LIVER CANCER

This study is looking back at how well newer drug treatments work for people with liver cancer. Researchers are reviewing the medical records of 2500 patients who received treatments like Keytruda, Tecentriq, and Lenvatinib between 2019 and 2024. The goal is to understand if thes…

This early-phase study is testing a new type of cell therapy called AGAR T cells in children and young adults with solid tumors that have come back or haven't responded to standard treatments. Doctors take a patient's own immune cells, modify them in a lab to better recognize and…

This study is testing a new way of giving an existing liver cancer drug called regorafenib. The goal is to see if starting with a lower dose and slowly increasing it over the first two months helps patients better tolerate the treatment and stay on it longer. It involves 28 peopl…

This study is testing whether the drug nivolumab can help prevent liver cancer from returning in people who are at high risk of recurrence after their initial tumor has been completely removed by surgery or destroyed by ablation. It compares nivolumab against a placebo in about 5…

This study is testing if a new type of catheter can better target radiation to liver tumors during a standard treatment called radioembolization. About 20 adults with liver cancer will have their standard treatment planning scan done with either the new device or a standard cathe…

This is an early-stage study to check the safety and find the right dose of a new drug called SH006 injection when given with standard cancer medications. It will involve about 50 adults with advanced solid tumors, like liver cancer, that have not responded to at least one prior …

This early-stage study is testing a new treatment called GAP T cells in children and young adults with liver cancer that has come back or hasn't responded to standard treatments. Doctors take a patient's own immune cells, genetically modify them in a lab to recognize and attack c…

This study is testing a new, FDA-approved electrical ablation technique for patients with liver cancer who cannot have surgery, specifically when tumors are dangerously close to major blood vessels. The procedure, called irreversible electroporation (IRE), uses high-voltage elect…

This early-stage study tests a personalized cell therapy for people with advanced solid tumors. Doctors collect a patient's own immune cells, genetically modify them in a lab to better recognize and attack cancer, then infuse them back into the patient. The main goals are to chec…

This study is testing whether tiny radioactive beads called Eye90 microspheres can help control liver cancer that cannot be surgically removed. The beads are delivered directly to the tumor through blood vessels to deliver radiation while sparing healthy liver tissue. Researchers…

This study is testing a new blood test called Oncoguard™ Liver to see how well it can find liver cancer early in people at high risk. It will compare the test's accuracy to standard ultrasound screening. The goal is to see if this blood test can be a reliable tool for monitoring …

This study is testing whether a specialized catheter called TriNav can make liver cancer radiation treatment planning more accurate. Researchers want to see if using this device helps the test dose better predict where the actual radioactive treatment will go in the liver. The go…

This study is testing a non-invasive ultrasound treatment called HIFU to relieve symptoms like pain in patients with abdominal tumors that cannot be surgically removed. The treatment uses focused sound waves to heat and destroy tumor tissue without needing needles or cuts. Resear…

This study aims to see if combining detailed MRI scans and full genetic sequencing of a patient's tumor can help doctors make better treatment decisions for liver cancer. It will observe 200 adults with liver tumors who are already scheduled for surgery. The goal is to gather inf…

This study aims to find patterns in the blood and immune system that can predict if liver cancer will come back after surgery. Researchers will collect blood and tissue samples from 360 patients in Vietnam who have had surgery to remove early-stage liver cancer. The goal is to id…

This study aims to collect leftover tissue and blood samples from people with cancer who are already having surgery or a biopsy. Researchers will study these samples to better understand cancer and find new targets for future treatments. The study will enroll about 1200 adults an…

This study collects leftover tissue and blood samples from patients with various cancers to help researchers understand these diseases better. The samples come from patients already having medical procedures, using only material that would otherwise be discarded. Researchers will…

This study aims to develop a better way to predict whether liver cancer ablation treatments are working. Researchers will analyze tissue samples from treated tumors to see if they can tell the difference between cancer cells and healthy cells that just look different after treatm…